Soltis Investment Advisors LLC Has $304,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Soltis Investment Advisors LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 582 shares of the medical equipment provider’s stock after purchasing an additional 63 shares during the period. Soltis Investment Advisors LLC’s holdings in Intuitive Surgical were worth $304,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of ISRG. Thurston Springer Miller Herd & Titak Inc. grew its holdings in Intuitive Surgical by 19.1% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,158 shares of the medical equipment provider’s stock worth $569,000 after acquiring an additional 186 shares during the period. ORG Wealth Partners LLC bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $65,000. Grove Bank & Trust increased its holdings in Intuitive Surgical by 9.5% in the third quarter. Grove Bank & Trust now owns 724 shares of the medical equipment provider’s stock worth $356,000 after purchasing an additional 63 shares in the last quarter. CX Institutional lifted its stake in Intuitive Surgical by 1.5% in the third quarter. CX Institutional now owns 1,873 shares of the medical equipment provider’s stock valued at $920,000 after buying an additional 28 shares during the period. Finally, Creative Planning boosted its holdings in shares of Intuitive Surgical by 9.3% during the 3rd quarter. Creative Planning now owns 68,881 shares of the medical equipment provider’s stock worth $33,839,000 after buying an additional 5,842 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 over the last three months. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

ISRG opened at $591.65 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a 50-day moving average of $555.91 and a 200 day moving average of $515.92. The firm has a market cap of $210.73 billion, a P/E ratio of 92.30, a PEG ratio of 5.67 and a beta of 1.39.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Barclays boosted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Bernstein Bank raised their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.